Clinical Trials

Boehringer Ingelheim will assess how monitoring cough and crackles with the RESP Biosensor can be used to monitor the status of patients with this disease.

Rich Christie, MD, PhD, Chief Medical Officer at AiCure discusses the use of the company's technology in a clinical trial for PTSD.

Ongoing efforts for standardization key in making data usable and trustworthy.

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

What is next for DCTs after acceleration from COVID-19?

In this interview, Dr. David Lee Scher adds his perspective on how digital health is changing in both healthcare and clinical trial settings.

How DCTs can impact pharmaceutical companies exploring DTx combination products and standalone DTx studies.

Benefits of business 4.0 approach in EDC in med-dev studies.